Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …
management of critically ill patients and beta-lactams are the most common antibiotic class …
Optimizing antimicrobial use: challenges, advances and opportunities
An optimal antimicrobial dose provides enough drug to achieve a clinical response while
minimizing toxicity and development of drug resistance. There can be considerable …
minimizing toxicity and development of drug resistance. There can be considerable …
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
G Wong, S Briscoe, B McWhinney, M Ally… - Journal of …, 2018 - academic.oup.com
Objectives To describe the achievement of unbound β-lactam antibiotic concentration
targets in a therapeutic drug monitoring (TDM) programme in critically ill patients, and the …
targets in a therapeutic drug monitoring (TDM) programme in critically ill patients, and the …
Pharmacokinetic and pharmacodynamic principles of anti-infective dosing
NJ Onufrak, A Forrest, D Gonzalez - Clinical therapeutics, 2016 - Elsevier
Purpose An understanding of the pharmacokinetic (PK) and pharmacodynamic (PD)
principles that determine response to antimicrobial therapy can provide the clinician with …
principles that determine response to antimicrobial therapy can provide the clinician with …
[HTML][HTML] Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives
F de Velde, JW Mouton, BCM de Winter… - Pharmacological …, 2018 - Elsevier
Because of increasing antimicrobial resistance and the shortage of new antibiotics, there is
a growing need to optimize the use of old and new antibiotics. Modelling of the …
a growing need to optimize the use of old and new antibiotics. Modelling of the …
The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship
MH Kollef, M Bassetti, B Francois, J Burnham… - Intensive care …, 2017 - Springer
Purpose To concisely describe the current standards of care, major recent advances,
common beliefs that have been contradicted by recent trials, areas of uncertainty, and …
common beliefs that have been contradicted by recent trials, areas of uncertainty, and …
[HTML][HTML] An approach to antibiotic treatment in patients with sepsis
ML Martínez, EP Plata-Menchaca… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Sepsis is a medical emergency and life-threatening condition due to a dysregulated host
response to infection, which is time-dependent and associated with unacceptably high …
response to infection, which is time-dependent and associated with unacceptably high …
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a …
DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - Springer
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization
Highlights•Augmented renal clearance (ARC) is a prevalent condition in the critically
ill.•ARC may result in sub-therapeutic exposure of renally eliminated antibiotics.•Beta …
ill.•ARC may result in sub-therapeutic exposure of renally eliminated antibiotics.•Beta …
Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …
however, controversy exists as to whether mortality in serious infections can be decreased …